Author
Listed:
- Qiuhui Li
(Roswell Park Comprehensive Cancer Center
Wuhan University
University of Texas M.D. Anderson Cancer Center)
- Bigang Liu
(University of Texas M.D. Anderson Cancer Center)
- Hsueh-Ping Chao
(University of Texas M.D. Anderson Cancer Center)
- Yibing Ji
(Roswell Park Comprehensive Cancer Center)
- Yue Lu
(University of Texas M.D. Anderson Cancer Center)
- Rashid Mehmood
(Roswell Park Comprehensive Cancer Center)
- Collene Jeter
(University of Texas M.D. Anderson Cancer Center)
- Taiping Chen
(University of Texas M.D. Anderson Cancer Center)
- John R. Moore
(University of Texas M.D. Anderson Cancer Center)
- Wenqian Li
(University of Texas M.D. Anderson Cancer Center)
- Can Liu
(University of Texas M.D. Anderson Cancer Center)
- Kiera Rycaj
(Roswell Park Comprehensive Cancer Center
University of Texas M.D. Anderson Cancer Center)
- Amanda Tracz
(Roswell Park Comprehensive Cancer Center)
- Jason Kirk
(Roswell Park Comprehensive Cancer Center)
- Tammy Calhoun-Davis
(University of Texas M.D. Anderson Cancer Center)
- Jie Xiong
(Roswell Park Comprehensive Cancer Center
University of Texas M.D. Anderson Cancer Center)
- Qu Deng
(Roswell Park Comprehensive Cancer Center
University of Texas M.D. Anderson Cancer Center)
- Jiaoti Huang
(Duke University of School of Medicine)
- Barbara A. Foster
(Roswell Park Comprehensive Cancer Center)
- Abhiram Gokhale
(Roswell Park Comprehensive Cancer Center)
- Xin Chen
(Roswell Park Comprehensive Cancer Center
University of Texas M.D. Anderson Cancer Center
Huazhong University of Science and Technology (HUST))
- Dean G. Tang
(Roswell Park Comprehensive Cancer Center
University of Texas M.D. Anderson Cancer Center
Tongji University School of Medicine)
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Suggested Citation
Qiuhui Li & Bigang Liu & Hsueh-Ping Chao & Yibing Ji & Yue Lu & Rashid Mehmood & Collene Jeter & Taiping Chen & John R. Moore & Wenqian Li & Can Liu & Kiera Rycaj & Amanda Tracz & Jason Kirk & Tammy C, 2020.
"Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer,"
Nature Communications, Nature, vol. 11(1), pages 1-1, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16615-9
DOI: 10.1038/s41467-020-16615-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16615-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.